Targeted forms of methyltrithio antitumor agents
AssigneeAmerican Cyanamid Company
InventorsGeorge A. Ellestad, William J. McGahren, Martin L. Sassiver, Philip R. Hamann, Lois M. Hinman, Janis Upeslacis
Life of this patent
Estimating the term…
Abstract
This disclosure describes a method for constructing carrier-drug conjugates from the family of methyltrithio antibacterial and antitumor agents.
Claims33
A carrier-drug conjugate of the formula ##STR22## prepared from a compound of formula CH.sub.3 SSS-W wherein CH.sub.3 SSS-W is an antitumor antibiotic designated as LL-E33288.alpha..sub.1.sup.Br, .alpha..sub.1.sup.I, .alpha..sub.2.sup.Br, .alpha..sub.3.sup.Br, .alpha..sub.3.sup.I, .alpha..sub.4.sup.Br, .beta..sub.1.sup.Br, B.sub.1.sup.I, .beta..sub.2.sup.Br, .beta..sub.2.sup.I, .gamma..sub.1.sup.Br, .gamma..sub.1.sup.I, .delta..sub.1.sup.I, the iodo or bromo pseudoaglycones, their dihydro or N-acyl counterparts, BBM-1675, FR-900405, FR-900406, PD 114759, PD 115028, CL-1577A, CL-1577B, CL-1577D, CL-1577E, CL-1724 or their N-acetyl counterparts comprising:
- reacting CH.sub.3 SSS-W with a compound of general formula A-Sp-SH, wherein Sp is a straight or branched-chain divalent or trivalent (C.sub.1 -C.sub.18) radical, divalent or trivalent aryl or heteroaryl radical, divalent or trivalent (C.sub.3 -C.sub.18) cycloalkyl or heterocycloalkyl radical, divalent or trivalent aryl-or heteroaryl-alkyl (C.sub.1 -C.sub.18) radical, divalent or trivalent cycloalkyl- or heterocycloalkyl-alkyl (C.sub.1 -C.sub.18) radical or divalent or trivalent (C.sub.2 -C.sub.18) unsaturated alkyl radical, wherein if Sp is a trivalent radical, it can be additionally substituted by amino, alkylamino, arylamino, heteroarylamino, carboxyl, lower alkoxy, hydroxy, thiol, or lower alkylthio groups;
- and Q is, or can be subsequently converted to, halogen, amino, alkylamino, carboxyl, carboxaldehyde, hydroxy, tiol, .alpha.-haloacetyloxy, lower alkyldicarboxyl, --CONHNH.sub.2, --NHCONHNH.sub.2, --NHCSNHNH.sub.2, --ONH.sub.2, --CON.sub.3, ##STR23## to produce an intermediate of formula Q-Sp-SS-W, wherein Q, Sp, and W are as hereinbefore defined,
- reacting Q-Sp-SS-W with a molecule of the formula Tu-(Y).sub.n wherein the carrier Tu is defined as a mono- or polyclonal antibody, its fragments, its chemically or genetically manipulated counterparts, or growth factors or steroids;
- Y is a side-chain amino, carboxy, or thiol group of a protein, an aldehyde derived from glycoprotein carbohydrate residues, or an amidoalkylathio group;
- and n is an integer of from 1 to 100, to produce a compound of the formula:
- ##STR24## wherein Tu, Y, Sp, W, and n are as hereinbefore defined, and Z is formed from covalent reaction of the groups Q and Y directly or after subsequent reduction, and Z is --CONH--, --CONHN.dbd.CH--, --CONHNHCH.sub.2 --, --NHCONHN.dbd.CH--, --NHCONHNHCH.sub.2, --NHCSNHN.dbd.CH--, --NHCSNHNHCH.sub.2 --, --OH.dbd.CH--, --NH--, --NHCH.sub.2 --, --N.dbd.CH--, --CO.sub.2 --, --NHCH.sub.2 CO.sub.2 --, --SS--, ##STR25## and m is 0.1 to 15.
Dependencies are inferred from the claim text.